Zentalis Pharmaceuticals (ZNTL) Stock Chart & Stock Price History $1.25 +0.01 (+0.81%) As of 07/3/2025 02:21 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Zentalis Pharmaceuticals Stock Price Performance The Zentalis Pharmaceuticals (ZNTL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 64.08%, with a year-to-date return of -58.75%. In the past month, the stock has decreased 16.67%, reflecting recent market activity. As of the latest close, Zentalis Pharmaceuticals traded at $1.25 with a market cap of $89.22 million and volume of 384,919 shares. Five years ago, the stock traded at $47.80, representing a 97.38% decrease over that period. At the time, it had a market cap of $1.72 billion and a volume of 161,000 shares. Receive ZNTL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zentalis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.93%1 Month Performance-16.67%3 Month Performance+6.84%Year-To-Date Performance-58.75%1 Year Performance-64.08%5 Year Performance-97.38% ZNTL Stock Chart for Friday, July, 4, 2025 ZNTL Chart by TradingView Zentalis Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$1.24$1.25+0.81%$1.28$1.24384,919 shs$89.22 million07/02/2025$1.19$1.24+4.20%$1.28$1.191.12 million shs$89.22 million07/01/2025$1.16$1.19+2.59%$1.27$1.131.16 million shs$85.62 million06/30/2025$1.18$1.16-1.69%$1.22$1.151.20 million shs$83.46 million06/27/2025$1.26$1.18-6.35%$1.29$1.168.82 million shs$84.90 million06/26/2025$1.31$1.26-3.82%$1.33$1.231.24 million shs$90.66 million06/25/2025$1.35$1.31-2.96%$1.37$1.30443,045 shs$94.25 million06/24/2025$1.30$1.35+3.85%$1.39$1.29641,317 shs$97.14 million06/23/2025$1.30$1.30$1.34$1.24608,957 shs$93.54 million06/20/2025$1.38$1.30-5.80%$1.41$1.241.29 million shs$93.54 million Get the Latest News and Ratings for ZNTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zentalis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$1.38$1.38$1.54$1.37717,400 shs$99.29 million06/18/2025$1.50$1.38-8.00%$1.54$1.37717,400 shs$99.29 million06/17/2025$1.51$1.50-0.66%$1.51$1.411.30 million shs$107.93 million06/16/2025$1.34$1.51+12.69%$1.51$1.33920,423 shs$108.65 million06/13/2025$1.46$1.34-8.22%$1.43$1.311.02 million shs$96.42 million06/12/2025$1.48$1.46-1.35%$1.49$1.42319,772 shs$105.05 million06/11/2025$1.63$1.48-9.20%$1.64$1.48853,704 shs$106.49 million06/10/2025$1.49$1.63+9.40%$1.67$1.491.04 million shs$117.28 million06/09/2025$1.52$1.49-1.97%$1.58$1.45845,565 shs$107.21 million06/06/2025$1.47$1.52+3.40%$1.56$1.45840,975 shs$109.37 million06/05/2025$1.50$1.47-2.00%$1.60$1.461.05 million shs$105.77 million06/04/2025$1.36$1.50+10.29%$1.51$1.292.23 million shs$107.93 million06/03/2025$1.28$1.36+6.25%$1.40$1.241.68 million shs$97.86 million Related Companies PRTA Stock Chart TERN Stock Chart PRME Stock Chart HUMA Stock Chart AQST Stock Chart SNDL Stock Chart HRTX Stock Chart AURA Stock Chart ALT Stock Chart CTOR Stock Chart Receive ZNTL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zentalis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZNTL) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zentalis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zentalis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
